Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Impact of Stopping Tumor Necrosis Factor-inhibitors on Rheumatoid Arthritis Patients' Burden of Disease.

Ghiti Moghadam M, Ten Klooster PM, Vonkeman HE, Kneepkens EL, Klaasen R, Stolk JN, Tchetverikov I, Vreugdenhil SA, van Woerkom JM, Goekoop-Ruiterman YPM, Landewé RBM, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

Arthritis Care Res (Hoboken). 2017 Jul 10. doi: 10.1002/acr.23315. [Epub ahead of print]

PMID:
28692770
2.

Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.

Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, Geurts MA, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FP, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group.

Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004.

PMID:
22393128
3.

Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.

Bakker MF, Jacobs JW, Kruize AA, van der Veen MJ, van Booma-Frankfort C, Vreugdenhil SA, Bijlsma JW, Lafeber FP, Welsing PM.

Ann Rheum Dis. 2012 Jun;71(6):830-5. doi: 10.1136/annrheumdis-2011-146670. Epub 2011 Nov 29.

PMID:
22128075
4.

Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study.

Bakker MF, Jacobs JW, Welsing PM, Vreugdenhil SA, van Booma-Frankfort C, Linn-Rasker SP, Ton E, Lafeber FP, Bijlsma JW; Utrecht Arthritis Cohort Study Group.

Ann Rheum Dis. 2011 Jun;70(6):1099-103. doi: 10.1136/ard.2010.137943. Epub 2011 Mar 15.

PMID:
21406458
5.

Treatment of pulmonary arterial hypertension.

Huisman AM, Vreugdenhil SA, van Paassen HC.

N Engl J Med. 2005 Jan 20;352(3):308-9; author reply 308-9. No abstract available.

Supplemental Content

Loading ...
Support Center